In-Person
Systematic Uptake and Standardization of Treatment Advances Through an Integrated Network (SUSTAIN) for Bispecific Antibody Therapy
Hosted by University of Kentucky Healthcare CE Central
May 18, 2026 Location TBD
About This Event
This continuing education program addresses gaps in Kentucky oncology providers' capacity to administer and manage Bispecific Antibody (BsAb) therapy for Multiple Myeloma patients. The course focuses on establishing protocols for BsAb administration, toxicity management, patient selection, emergency response, and quality monitoring to enable safe and effective treatment delivery in community oncology settings.
Sign in to unlock everything networkED.global adds to this event
We enrich every event with details scattered across the web — organized, verified, in one place:
- Earning CE? CE credits, accreditation, and which licenses it counts toward — tracked automatically.
- Speaking? Call-for-proposal deadlines and submission details.
- Exhibiting or sponsoring? Exhibit and sponsorship opportunities.
- Hosting events? Be connected directly to your target audiences.
Plus full agenda, pricing, registration, contacts, and topics covered.